MedDataX Logo

Latent Myofascial Trigger Points in the Craniocervical Region

NCT ID: NCT03327545

Last Updated: 2017-10-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-31

Study Completion Date

2017-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Myofascial pain is a clinical problem that has generated interest, debate and confusion for decades. According to studies anywhere between 33 and 97 % of patients with musculoskeletal pain visiting physicians and manual therapists are diagnosed with Myofascial Trigger Points (MTrPs). MTrPs are localized, hyperirritable points that are associated with palpable nodules in taut bands (TB) of muscle fibres. MTrPs can be classified into active and latent. Latent MTrPs demonstrate the same clinical characteristics as active MTrPs but they do not provoke spontaneous pain. The myofascial trigger points (MTrPs) are common in healthy subjects and in patients with musculoskeletal pain, and could produce sensitive disturbances and motor dysfunctions

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myofascial Pain Syndrome

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Trigger points Trigegeminal nerve Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental Group 1

Neural mobilization for a total of 12 minutes

Group Type EXPERIMENTAL

Neural mobilization

Intervention Type DEVICE

Neural mobilization on the right side of the craniocervical region for a total of 12 minutes.

Experimental Group 2

Soft tissue techniques and Stretching right side of the craniocervical for a total of 12 minutes

Group Type EXPERIMENTAL

Soft tissue techniques and Stretching

Intervention Type DEVICE

Soft tissue techniques and Stretching on the right side of the craniocervical region for a total of 12 minutes

Control group

Control group

Group Type PLACEBO_COMPARATOR

Control group

Intervention Type DEVICE

Did not receive any treatment.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Neural mobilization

Neural mobilization on the right side of the craniocervical region for a total of 12 minutes.

Intervention Type DEVICE

Soft tissue techniques and Stretching

Soft tissue techniques and Stretching on the right side of the craniocervical region for a total of 12 minutes

Intervention Type DEVICE

Control group

Did not receive any treatment.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Neck pain

Exclusion Criteria

* myelopathy
* fracture
* infection
* dystonia
* tumor
* inflammatory disease
* fibromyalgia
* or osteoporosis
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fondazione Don Carlo Gnocchi Onlus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jorge Hugo Villafañe, PhD

Researcher

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

JORGE H VILLAFAÑE

Role: PRINCIPAL_INVESTIGATOR

IRCCS Don Gnocchi Foundation

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LMTrP

Identifier Type: -

Identifier Source: org_study_id